NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 63323-0852-03 — Hydromorphone injection, 1 mg per mL vialAI (576 hospitals, 23,653–34,435 samples)
• NDC 69339-0138-15 — Chlorhexidine gluconate 0.12% rinseAI (453 hospitals, 32,187–34,419 samples)
• NDC 64980-0515-05 — Ofloxacin 0.3% eye dropsAI (677 hospitals, 32,993–34,397 samples)
• NDC 00904-6440-61 — Hydralazine 10 mg tabletsAI (333 hospitals, 33,739–34,396 samples)
• NDC 00904-6082-61 — Zolpidem 5 mg tabletAI (903 hospitals, 33,700–34,393 samples)
• NDC 00904-6371-61 — Amlodipine 10 mg tabletAI (628 hospitals, 33,518–34,373 samples)
• NDC 23155-0026-01 — Verapamil 80 mg tabletsAI (824 hospitals, 33,661–34,354 samples)
• NDC 00904-6426-61 — Escitalopram 10 mg tabletAI (862 hospitals, 33,534–34,335 samples)
• NDC 43598-0548-21 — PROPOFOL 10 MG/ML INTRAVENOUS EMULSIONAI (192 hospitals, 32,642–34,334 samples)
• NDC 61314-0355-02 — Tropicamide 1% eye dropsAI (526 hospitals, 33,246–34,299 samples)
• NDC 00172-4096-60 — baclofen 10 mg tabletAI (374 hospitals, 33,558–34,296 samples)
• NDC 00409-6727-23 — Magnesium sulfate in dextrose IV solutionAI (607 hospitals, 31,877–34,289 samples)
• NDC 00517-6101-01 — Zinc sulfate intravenous solutionAI (121 hospitals, 33,516–34,272 samples)
• NDC 59762-3304-03 — Nitroglycerin 0.4 mg sublingual tabletAI (678 hospitals, 33,316–34,261 samples)
• NDC 17478-0206-05 — PHENYLEPHRINE 10 % EYE DROPSAI (295 hospitals, 33,341–34,232 samples)
• NDC 00904-6667-61 — Gabapentin 400 mg capsulesAI (695 hospitals, 33,329–34,211 samples)
• NDC 48102-0057-11 — Erythromycin 0.5% eye ointmentAI (292 hospitals, 33,225–34,206 samples)
• NDC 55150-0171-10 — Bupivacaine 0.75% injection, preservative-freeAI (598 hospitals, 27,559–34,102 samples)
• NDC 00006-0227-61 — Raltegravir 400 mg tabletAI (1003 hospitals, 33,371–34,091 samples)
• NDC 00904-6798-61 — Lisinopril 10 mg tabletsAI (764 hospitals, 33,322–34,069 samples)
• NDC 00338-0551-18 — Dextrose 5% in water IV bagAI (419 hospitals, 32,917–34,069 samples)
• NDC 23155-0345-31 — Propofol injection 10 mg/mL, 20 mLAI (99 hospitals, 33,611–34,061 samples)
• NDC 63323-0186-20 — Sodium chloride 0.9% preservative-free injectionAI (373 hospitals, 33,244–34,045 samples)
• NDC 00121-4950-40 — Lidocaine viscous 2% oral solutionAI (577 hospitals, 32,505–34,044 samples)
• NDC 24208-0720-02 — Dexamethasone sodium phosphate eye dropsAI (1079 hospitals, 32,775–34,026 samples)
• NDC 65162-0896-03 — Aripiprazole 2 mg tabletsAI (452 hospitals, 33,263–34,019 samples)
• NDC 10572-0100-01 — Polyethylene glycol electrolyte oral solutionAI (519 hospitals, 33,380–33,983 samples)
• NDC 00409-1312-03 — Hydromorphone 2 mg/mL injection syringeAI (416 hospitals, 25,473–33,978 samples)
• NDC 24208-0830-60 — Neomycin, polymyxin, and dexamethasone eye drop suspensionAI (959 hospitals, 32,771–33,968 samples)
• NDC 25021-0686-20 — Vecuronium bromide 20 mg IV injectionAI (144 hospitals, 33,219–33,939 samples)
• NDC 45963-0438-64 — Lactulose oral solution, 10 grams per 15 mLAI (463 hospitals, 32,688–33,939 samples)
• NDC 00904-7162-61 — Metformin 500 mg tabletsAI (630 hospitals, 33,242–33,935 samples)
• NDC 69238-1615-03 — Ofloxacin 0.3% ear dropsAI (284 hospitals, 32,935–33,925 samples)
• NDC 63323-0492-31 — Xylocaine (lidocaine) 1% injection solutionAI (270 hospitals, 31,197–33,924 samples)
• NDC 61314-0354-01 — Tropicamide 0.5% eye dropsAI (431 hospitals, 32,828–33,917 samples)
• NDC 43598-0210-40 — silver sulfADIAZINE 1 % topical creamAI (517 hospitals, 32,915–33,905 samples)
• NDC 17478-0209-19 — Ketorolac eye drops, 3 mL bottleAI (229 hospitals, 33,182–33,902 samples)
• NDC 00378-4642-16 — Estradiol transdermal patch, twice weeklyAI (142 hospitals, 33,153–33,900 samples)
• NDC 00264-7622-00 — Dextrose and sodium chloride IV solutionAI (375 hospitals, 32,286–33,897 samples)
• NDC 31722-0778-01 — Acyclovir 800 mg tabletAI (344 hospitals, 33,161–33,881 samples)
• NDC 60758-0773-05 — Ketorolac eye dropsAI (260 hospitals, 32,893–33,874 samples)
• NDC 65219-0184-01 — KETAMINE 10 MG/ML INJECTION SOLUTIONAI (219 hospitals, 32,621–33,863 samples)
• NDC 00143-9333-10 — Bupivacaine 0.25% numbing injectionAI (213 hospitals, 30,801–33,825 samples)
• NDC 00409-4887-10 — Sterile water for injectionAI (608 hospitals, 33,379–33,820 samples)
• NDC 63323-0495-26 — Lidocaine (preservative-free) 2% injection solutionAI (232 hospitals, 31,977–33,813 samples)
• NDC 61314-0126-05 — Ketorolac eye dropsAI (814 hospitals, 32,542–33,802 samples)
• NDC 00527-5125-70 — Lactulose 10 g/15 mL oral solutionAI (220 hospitals, 32,654–33,797 samples)
• NDC 00187-4330-05 — Isoproterenol injectionAI (165 hospitals, 33,462–33,777 samples)
• NDC 63323-0484-57 — Xylocaine 0.5% injectable lidocaine solutionAI (410 hospitals, 31,909–33,772 samples)
• NDC 00904-6797-61 — Lisinopril 5 mg tabletAI (826 hospitals, 32,734–33,769 samples)